Multiple Metastatic Deposits in the Head and Neck Region from a Renal Cell Carcinoma

被引:0
|
作者
Ishak, Azlan Iskandar [1 ]
Pauzi, Suria Hayati Md [2 ]
Masir, Noraidah [2 ]
See, Goh Bee [1 ]
机构
[1] Univ Kebangsaan Malaysia, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, Med Ctr, Dept Pathol, Kuala Lumpur 56000, Malaysia
来源
MALAYSIAN JOURNAL OF MEDICAL SCIENCES | 2010年 / 17卷 / 04期
关键词
cancer of the head and neck; diagnostic imaging; neoplasm metastases; oncology; renal cell carcinoma; signs and symptoms;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Metastatic renal cell carcinoma (RCC) presenting with multiple deposits in the head and neck region is unusual. It is not uncommon for a RCC to metastasise to a distant site after years of a tumour-free period, but most of it would be expected to have a single site of deposit. We report a rare case of a patient who had a nephrectomy 10 years earlier for RCC and presented with tumours in the frontal sinus and posterior pharyngeal wall. Radiological imaging and histology confirmed metastatic RCC at both sites.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [31] Basal Cell Carcinoma of the Head and Neck Region in Ethnic Chinese
    Chow, Velda Ling Yu
    Chan, Jimmy Yu Wai
    Chan, Richie Chiu Lung
    Chung, Joseph Hon Ping
    Wei, William Ignace
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2011, 2011
  • [32] Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck
    Nishimura, Ari
    Yokota, Tomoya
    Iida, Yoshiyuki
    Kamijo, Tomoyuki
    Mukaigawa, Takashi
    Onozawa, Yusuke
    Todaka, Akiko
    Hamauchi, Satoshi
    Kawakami, Takeshi
    Shirasu, Hiromichi
    Onoe, Tsuyoshi
    Ogawa, Hirohumi
    Kawabata, Takanori
    Yasui, Hirofumi
    Onitsuka, Tetsuro
    ANNALS OF ONCOLOGY, 2021, 32 : S296 - S296
  • [33] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [34] HEAD AND NECK SQUAMOUS-CELL CARCINOMA METASTATIC TO THE ORBITAL APEX
    DAY, TA
    HOASJOE, DK
    HEBERT, RL
    GONZALEZ, E
    SHOCKLEY, W
    STUCKER, FJ
    NANDA, A
    SKULL BASE SURGERY, 1995, 5 (02): : 123 - 129
  • [35] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [36] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [37] Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
    Gauduchon, Thibault
    Neidhardt, Eve Marie
    Fayette, Jerome
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 175 - 183
  • [38] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [39] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [40] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177